Wikidata

(Q60632684)

English

Clinical outcomes in patients with castrate-refractory prostate cancer (CRPC) metastatic to bone randomized in the factorial TRAPEZE trial to docetaxel (D) with strontium-89 (Sr89), zoledronic acid (ZA), neither, or both (ISRCTN 12808747)

No description defined

In more languages

Statements

title
Clinical outcomes in patients with castrate-refractory prostate cancer (CRPC) metastatic to bone randomized in the factorial TRAPEZE trial to docetaxel (D) with strontium-89 (Sr89), zoledronic acid (ZA), neither, or both (ISRCTN 12808747) (English)
0 references
author name string
Nicholas David James
series ordinal
1
0 references
Sarah Pirrie
series ordinal
2
0 references
Darren Barton
series ordinal
3
0 references
Janet Elizabeth Brown
series ordinal
4
0 references
Lucinda Billingham
series ordinal
5
0 references
Stuart I. Collins
series ordinal
6
0 references
Adam Daunton
series ordinal
7
0 references
Alison J. Birtle
series ordinal
8
0 references
Prabir Ranjan Chakraborti
series ordinal
9
0 references
Daniel Ford
series ordinal
10
0 references
Syed A. Hussain
series ordinal
11
0 references
Helen Jones
series ordinal
12
0 references
Ann Pope
series ordinal
13
0 references
Emilio Porfiri
series ordinal
14
0 references
John Martin Russell
series ordinal
15
0 references
Andrew Stanley
series ordinal
16
0 references
John Staffurth
series ordinal
17
0 references
Duncan McLaren
series ordinal
18
0 references
Chris Parker
series ordinal
19
0 references
James Wylie
series ordinal
20
0 references
publication date
20 June 2013
0 references
volume
31
0 references
issue
18_suppl
0 references
page(s)
LBA5000-LBA5000
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q60632684&oldid=1577694391"